Otsuka Holdings raises first-half profit forecast on strong performance

Otsuka Holdings revised its first-half fiscal 2025 forecast, raising revenue expectations to 1.18 trillion yen from 1.174 trillion yen. Profit attributable to owners jumped to an expected 173 billion yen from 147 billion yen.

The upgrade reflects strong pharmaceutical sales of Rexulti, ABILIFY MAINTENA, and JYNARQUE, plus robust nutraceutical sales from POCARI SWEAT and EQUELLE. Lower-than-planned administrative and research expenses also contributed.